Clearmind Medicine Inc. Quarterly Research And Development Expense in CAD from Q4 2021 to Q4 2022

Taxonomy & unit
ifrs-full: CAD and USD
Summary
Clearmind Medicine Inc. quarterly/annual Research And Development Expense history and growth rate from Q4 2021 to Q4 2022.
  • Clearmind Medicine Inc. Research And Development Expense for the quarter ending January 31, 2023 was CA$792K, a 86.8% increase year-over-year.
  • Clearmind Medicine Inc. annual Research And Development Expense for 2022 was CA$4.21M, a 550% increase from 2021.
Research And Development Expense, Quarterly (CAD)
Research And Development Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.